Kathy Wilkinson on the Nurse's Role in Clinical Trials

Video
Conferences|ONS Annual Congress

Kathy Wilkinson, RN, BSN, OCN, Manager, Cancer Research, Billings Clinic Cancer Center, discusses the role that nurse's play in clinical trials.

Kathy Wilkinson, RN, BSN, OCN, Manager, Cancer Research, Billings Clinic Cancer Center, discusses the role that nurses play in clinical trials.

Wilkinson says a nurse’s relationship with a patient puts them in a prime position to talk about clinical trials. Nurses can educate patients about clinical trials and explain concepts to patients in terms that they can understand. Wilkinson says patients trust nurses to give them accurate information about what the trial is going to entail, including potential side effects.

<<<

View more from the 40th Annual ONS Congress

Newsletter

Stay up to date on recent advances in oncology nursing and patient care.

Subscribe Now!
Recent Videos
Image of a woman with gray hair and glasses in front of a blue Oncology Nursing News background
Photo of a woman with blond wavy hair wearing a blazer in front of a blue Oncology Nursing News background
Photo of a woman with shoulder-length blond hair in front of an Oncology Nursing News backdrop
Image of a woman with white hair in front of an Oncology Nursing News blue background
Image of a man in a suit standing in front of a blue Oncology Nursing News backdrop
Man in suit standing in front of blue watercolor Oncology Nursing News backdrop
Image of a woman in front of a blue Oncology Nursing News-branded backdrop.
Man standing in front of Oncology Nursing News-branded backdrop
a man wearing a suit and tie in front of a green screen with the ONN logo
Related Content
Image of red blood cells

Cilta-Cel Improves QOL, Extends Treatment Breaks vs SOC in R/R Myeloma

Ashling Wahner
April 22nd 2025
Article
The Vitals

Lauren Mahon Offers Nurse Perspectives on PARP Inhibitors As Ovarian Cancer Maintenance Therapy

Lindsay Fischer
June 15th 2023
Podcast

Lauren Mahon, MSN, FNP-BC, breaks down what oncology nurses should know about PARP inhibitors in ovarian cancer.

Image of blood with leukemia cells present

Variability Found in PROs, Gene Expression During AML Induction Chemo

Chris Ryan
April 21st 2025
Article

Gene expression in peripheral blood as well as patient-reported outcomes differed for those with acute myeloid leukemia undergoing induction chemotherapy.

The Vitals

Seth Eisenberg Discusses New Methods of Reducing Hazardous Drug–Contaminated Toilet Aerosols in Hospital Setting

Lindsay Fischer
June 1st 2023
Podcast

Seth Eisenberg, ASN, RN, OCN, BMTCN, emphasizes the importance of reducing nurse exposure to hazardous drugs—and ongoing research efforts to improve nursing safety.

Image of red blood cells

Daratumumab Decreased Progression Risk in High-Risk Smoldering MM

Jax DiEugenio
April 19th 2025
Article

Daratumumab showed a decrease in disease progression or death risk vs active monitoring in patients with high-risk smoldering multiple myeloma.

Image of patients of different ages in a waiting room

Risk Factors Determine Symptom Burden Profiles by Age Group

Bridget Hoyt
April 18th 2025
Article

Emetogenic chemotherapy regimens and back pain were associated with higher symptom burden in older, vs younger, patients with cancer.